RKDA RKDA

Q: What is the current share price of RKDA?

As of 2026-08-05 17:25 PDT, RKDA trades at $0.70 on NASDAQ/NYSE. Its 52-week range is $0.62 to $5.48.

Q: What is the market capitalisation of RKDA?

RKDA has a market capitalisation of $961.18K on NASDAQ/NYSE.

Q: What is the P/E ratio of RKDA?

RKDA trades at a trailing price-to-earnings (P/E) ratio of -0.41. Its price-to-book (P/B) ratio is 0.23.

Q: What is the return on equity (ROE) of RKDA?

RKDA has a return on equity (ROE) of -56.50%.

Q: Is RKDA a good stock to buy?

This page provides a data-driven analysis of RKDA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$0.70

-83.79% 1Y

Mkt Cap$961.18K

P/E-0.41

P/B0.23

52W High$5.48

52W Low$0.62

Book Value$3.02

EPS (TTM)$-1.71

Company Overview

RKDA (RKDA) is a publicly traded company listed on with a market capitalization of $961.18K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.00.

Recent Developments

Dec 2025 Revenue of $4.86M (-3.7% YoY); net profit $-2.34M.
Trailing 12 Months Year-on-year growth — revenue -3.7%.
5-Year Trend Long-term compounding — revenue CAGR -3.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	-3.56%
1 Year:	-3.71%

Stock Price Performance

1 Year:	-83.79%
6 Months:	-64.30%
3 Months:	-38.84%
1 Month:	+0.04%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 2% of range

$0.62 $5.48

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)52.02 · Neutral

Price Performance

1M+0.04%

3M-38.84%

6M-64.30%

1Y-83.79%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

Revenue declined at -3.6% CAGR over 5 years.
Trading 87.2% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-0.41

Industry PE

Forward P/E

PEG Ratio

Book Value

$3.02

Price to Book

0.23

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

-3.56%

Profit 5Y

Revenue (YoY)

-3.71%

Earnings (YoY)

Profitability & Returns

ROCE

ROE

-56.50%

ROA

-35.73%

Profit Margin

-48.15%

Op Margin

Gross Margin

36.23%

EPS (Latest Qtr)

$-2.11

EPS (TTM)

$-1.71

Balance Sheet & Liquidity

Debt/Equity

0.00

Quick Ratio

2.50

Current Ratio

3.09

Debt

Total Assets

$5.32M

Current Assets

$5.17M

Working Capital

$4.30M

Ownership

Promoter Holding

0.16%

Chg in Prom Hold

FII / Inst Holding

16.02%

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

$4.86M

EBITDA

$-9.96M

Free Cash Flow

$-4.74M

Operating Cash Flow

$-4.74M

Shares Outstanding

1.37M

Gross Margin

36.23%

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Mar 2014	Jun 2014	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Mar 2017	Jun 2017	Sep 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	214.00K	436.00K	370.00K	158.00K	203.00K	392.00K	309.00K	281.00K	314.00K	828.00K	1.41M	2.38M	3.22M	3.86M	1.57M	1.23M	1.30M	1.30M	987.00K	1.31M	1.54M	-	1.20M	1.46M	1.30M	901.00K	1.10M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	682.00K	824.00K	884.00K	709.00K	700.00K
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	518.00K	631.00K	418.00K	192.00K	400.00K
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.74M	6.62M	1.83M	1.57M	1.18M
Operating Income	-2.58M	-5.00M	-5.94M	-3.71M	-3.55M	-4.24M	-4.93M	-4.29M	-3.93M	-3.96M	-3.74M	-3.62M	-3.84M	-4.58M	-4.10M	-4.22M	-4.98M	-6.19M	-5.79M	-6.88M	-7.58M	-5.33M	-7.68M	-8.71M	-4.62M	-3.78M	-3.99M	-3.87M	-1.45M	-1.40M	-1.59M	1.98M	-1.76M	-	-1.22M	-5.99M	-1.41M	-1.38M	-779.00K
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.21M	-5.97M	-1.41M	-1.37M	-771.00K
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.60M	-4.46M	856.00K	-1.33M	-4.38M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.00K	-	-	-	-	-
Net Income	-3.48M	-5.81M	-7.06M	-5.80M	-3.68M	-4.62M	-5.19M	-4.55M	-4.17M	-4.22M	-4.01M	-4.53M	-10.62M	-6.67M	4.45M	-12.61M	4.24M	-14.19M	2.52M	-9.69M	-6.39M	2.06M	-5.26M	-2.17M	-4.49M	-3.78M	-2.87M	-9.38M	823.00K	-2.57M	-2.42M	1.06M	-1.61M	-	2.60M	-4.46M	856.00K	-1.34M	-4.38M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2.64	0.84	-2.04	0.29	-1.04	-0.60	0.11	-0.24	-0.10	-8.09	-6.81	-4.67	-10.86	0.61	-1.89	-1.78	0.78	-1.18	-	1.90	-3.26	0.62	-	-2.11
R&D Expense	1.98M	2.27M	3.68M	1.83M	2.09M	3.18M	2.20M	2.22M	2.25M	1.82M	1.67M	1.75M	1.40M	1.79M	1.33M	1.50M	1.95M	1.93M	2.24M	1.99M	1.76M	1.16M	1.13M	1.04M	395.00K	359.00K	255.00K	359.00K	27.00K	15.00K	6.00K	10.00K	24.00K	-	0	9.00K	0	-	-

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	6.98M	5.41M	3.19M	4.03M	1.46M	1.17M	8.03M	-	7.42M	4.45M	5.04M	4.86M
Cost of Revenue	-	-	-	-	-	-	-	-	6.10M	2.17M	2.96M	3.10M
Gross Profit	-	-	-	-	-	-	-	-	1.32M	2.28M	2.08M	1.76M
Operating Expenses	-	-	-	-	-	-	-	-	16.55M	8.30M	9.69M	11.76M
Operating Income	-15.15M	-15.56M	-18.62M	-14.31M	-16.87M	-19.38M	-12.78M	-	-15.23M	-6.02M	-7.61M	-9.99M
EBITDA	-	-	-	-	-	-	-	-	-14.75M	-5.73M	-7.50M	-9.96M
Interest Expense	-	-	-	-	-	-	-	20.00K	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-10.81M	-5.32M	-4.31M	-2.33M
Tax Provision	-	-	-	-	-	-	-	-	14.00K	8.00K	8.00K	8.00K
Net Income	-18.34M	-17.96M	-19.62M	-15.71M	-13.48M	-28.80M	-4.66M	-	-15.38M	-13.98M	-7.04M	-2.34M
Diluted EPS	-	-	-	-	-	-	-	-	-25.65	-11.29	-5.17	-1.71
R&D Expense	10.01M	8.97M	8.66M	7.41M	6.07M	7.10M	7.96M	3.89M	1.51M	64.00K	53.00K	9.00K

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Sep 2020	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	24.89M	74.24M	56.57M	16.57M	24.02M	32.57M	-	47.35M	-	28.92M	19.70M	13.52M	6.55M
Current Assets	-	-	-	-	-	-	-	-	-	-	25.40M	14.97M	9.24M	6.36M
Cash & Equivalents	2.83M	16.57M	23.97M	2.01M	9.12M	12.00M	8.42M	-	14.04M	-	20.64M	6.52M	4.24M	259.00K
Inventory	-	-	-	-	-	-	-	-	-	-	2.32M	837.00K	904.00K	1.21M
Receivables	-	-	-	-	-	-	-	-	-	-	1.22M	506.00K	1.18M	425.00K
Total Liabilities	-	26.77M	34.02M	34.38M	8.56M	11.21M	24.25M	-	18.80M	-	8.02M	7.00M	7.29M	2.41M
Current Liabilities	-	11.27M	3.45M	3.13M	3.52M	3.05M	5.71M	-	6.31M	-	4.21M	3.59M	2.56M	2.06M
Long Term Debt	-	8.87M	24.93M	25.13M	0	0	107.00K	3.25M	2.10M	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	2.02M	1.01M	155.00K	0
Total Equity	-17.30M	-84.77M	40.23M	22.20M	8.01M	12.81M	7.71M	-	27.73M	-	21.03M	12.84M	6.22M	4.14M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	616.08K	1.29M	1.36M	1.37M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-	-	-	-13.96M	-13.63M	-17.20M	-30.22M	-	-13.98M	-15.29M	-9.63M	-4.74M
Investing Cash Flow	-	-	-	47.18M	-5.97M	-8.37M	17.28M	-	1.42M	-4.34M	7.34M	750.00K
Financing Cash Flow	-	-	-	-26.10M	22.48M	21.99M	20.56M	-	4.52M	5.51M	9.00K	6.00K
Capital Expenditure	-148.00K	-151.00K	-231.00K	-79.00K	-250.00K	-1.48M	-2.33M	-1.01M	-72.00K	-5.00K	-16.00K	-
Free Cash Flow	-	-	-	-14.04M	-13.88M	-18.68M	-32.55M	-	-14.05M	-15.30M	-9.64M	-4.74M
Net Change in Cash	-	-	-	-	-	-	-	-	-8.04M	-14.13M	-2.28M	-3.98M

Ratios (Annual)

Figures in %.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	17.8%	51.2%	41.3%	36.2%
Operating Margin %	-217.0%	-287.5%	-584.1%	-355.6%	-1,152.3%	-1,657.9%	-159.0%	-	-205.3%	-135.1%	-150.9%	-205.7%
Net Margin %	-262.7%	-331.7%	-615.6%	-390.1%	-920.8%	-2,464.1%	-57.9%	-	-207.3%	-313.9%	-139.5%	-48.1%
ROE %	21.6%	-44.6%	-88.4%	-196.2%	-105.2%	-373.8%	-16.8%	-	-73.1%	-108.9%	-113.1%	-56.5%
ROCE %	-111.3%	-22.0%	-34.8%	-109.7%	-80.4%	-72.1%	-31.1%	-	-61.6%	-37.3%	-69.5%	-222.8%

Shareholding Pattern

Insiders

0.16%

Institutions

16.02%

Public Float

16.04%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for RKDA

Google News Mon, 12 Jan 2026

Arcadia Bioscien (RKDA) Stock News & Updates - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTFB6bFZRQjRkcG1rODZxeFY0ZVk3UmdHVlJCWGJrYVRWTE1WMTRjSm4xRmY2UXVTQ3llY1gxQlQyNW5BOWQwQS1lOVVSenB1UQ?oc=5" target="_blank">Arcadia Bioscien (RKDA) Stock News & Updates</a>  <…

Google News Fri, 12 Jun 2026

Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million | RKDA Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxOdkhnQVBKeFVTaHpZcVNTbWZGWnVCNVdaYmZtWmNqdXBWbGpIN3I4SE12WUVhMmhMQ0prS3VPYWRqQUc0UzNWY3JRbVk5UWZJeF9OaHNqVlNsSXowcGYwUGIwSmEycXA1VWNaVnktR2NVS0tQbTNPNWxVU1RKYTFvakhZWmdIaUN6ZjB3R3…

Google News hu, 11 Jun 2026

RKDA Stock Whipsaws As Traders Focus On Cash, Chart - StocksToTrade

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQQnpYMFRMeDI3TEhLWnNZd0lPcVBqRmNfSl9NbnE3MHdWZUJZUkgxMm5YQXdnd1BtQWZxNy1hTzdCS2I4ZVNocWx5NzZyeWhLbG4yS2ljM3N6UXZqWjRNNlFabkt3ejN0ZWFaWlQ1RmEzR2JLZC1zZ1ZPZDdTNmpXaFFB?oc=5" target=…

Google News hu, 11 Jun 2026

RKDA Stock Slides As Volatile Chart Tests Day Traders - timothysykes.com

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNbEVEMFlTYlVBWVppNUVKSmtYeU5SZklVNkV0VTd5NElFeHlzYXREZEhPT2tCbDRnZ2xVd0thSkJycFd5VkEzc3ROd0VrRWV4UzhkOU9USGdlVF9NZl9ZeWpRaDZrZnBlREZMV3BDR0t1WkRCbkxOQlV6M3EwbTRmRg?oc=5" target="_…

Google News hu, 30 Jul 2026

RKDA|Arcadia Biosciences Inc|Price:0.625|Chg%:-0.008 - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE8yS1RQMklaY25JTEhrUzVUYU5KbzBxem1wYjBRd2tRdklibWVMLW5LOVkzNmpzZ1Zmd3pSQ2htR002WkRISWN3RE1wQVFEYk1paGVQRGw5VXNRWWlHS3lkTV9JNXdBUm5qMG9NQ01n?oc=5" target="_blank">RKDA|Arcadia Biosci…

Google News Sat, 01 Aug 2026

Arcadia Biosciences (RKDA) Slides 3.8% to $0.62 as Support Holds Near $0.59 - Fibonacci Entry Signals - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPWEh1ZURMdnlLVHdmZm9DeDcwNlBlRXlqbmxBNWpCaGtPVkJZd3lEakh0aExoVS1nTWstdFlVczlkVXphQUo5aHZrQm13cUdQcWRqUlVid1dHLWdOWVJoT1dreW1CWW5NOVlmQ3kwTHE3dzhGeGlzcHBxbG9qQkdNZVhRRUJoY0dBcnRrNW…

RKDA — Frequently Asked Questions

What is the current share price of RKDA?

As of 2026-08-05 17:25 PDT, RKDA trades at $0.70 on NASDAQ/NYSE. Its 52-week range is $0.62 to $5.48.

What is the market capitalisation of RKDA?

RKDA has a market capitalisation of $961.18K on NASDAQ/NYSE.

What is the P/E ratio of RKDA?

RKDA trades at a trailing price-to-earnings (P/E) ratio of -0.41. Its price-to-book (P/B) ratio is 0.23.

What is the return on equity (ROE) of RKDA?

RKDA has a return on equity (ROE) of -56.50%.

Is RKDA a good stock to buy?

This page provides a data-driven analysis of RKDA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

RKDA RKDA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

Arcadia Bioscien (RKDA) Stock News & Updates - Stock Titan

Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million | RKDA Stock News - Quiver Quantitative

RKDA Stock Whipsaws As Traders Focus On Cash, Chart - StocksToTrade

RKDA Stock Slides As Volatile Chart Tests Day Traders - timothysykes.com

RKDA|Arcadia Biosciences Inc|Price:0.625|Chg%:-0.008 - TradingKey

Arcadia Biosciences (RKDA) Slides 3.8% to $0.62 as Support Holds Near $0.59 - Fibonacci Entry Signals - dars.gov.et

RKDA — Frequently Asked Questions

What is the current share price of RKDA?

What is the market capitalisation of RKDA?

What is the P/E ratio of RKDA?

What is the return on equity (ROE) of RKDA?

Is RKDA a good stock to buy?

Explore More